I. L.
October 2007
Red Herring;10/7/2007, Vol. 4 Issue 29, p46
Trade Publication
The article features Redwood, California-based Codexis, a technology company included in "Red Herring's" top 100 list for 2007. Alan Shaw is the chief executive officer of the company. Investors include CMEA Ventures, Pequot, Chevron Technology Ventures, Pfizer and Bio One Capital. Codexis is using enzymes to convert biomass to biofuel in partnership with Shell. The big challenge in biofuels is to create a cheap, mass-produced enzyme that can break cellulose into sugars. But Codexis is not the only company tackling that challenge.


Related Articles

  • Codexis On Track Despite Executive Exodus. Coons, Rebecca // Chemical Week;2/27/2012, Vol. 174 Issue 7, p29 

    The article reports that Codexis Inc. is still working well even after chief financial officer (CFO) Bob Lawsen and chief executive officer (CEO) Alan Shaw left the company.

  • Codexis Announces Inducement Option Award and Restricted Stock Award to John J. Nicols.  // Biomedical Market Newsletter;6/18/2012, Vol. 21, p1 

    The article informs that Codexis Inc. has granted John J. Nicols, its chief executive officer the stock option award and restricted stock award. Through these awards Codexis granted Nicols an option to purchase 400,000 shares of Codexis' common stock with an exercise price equal to 3.46 dollars...

  • FDA Approves Use of Codexis Enzymes in Merck Manufacturing Process.  // Biomedical Market Newsletter;4/28/2012, Vol. 21, p1 

    The article reports on an announcement made by Codexis Inc., developer of industrial enzymes, related to an approval by the U.S. Food and Drug Administration (FDA) to a new process for the manufacture of sitagliptin, an active pharmaceutical ingredient, which has been co-developed by Codexis. As...

  • USPTO Grants Codexis Patent for Enzymes Used in Hep-C Therapeutics.  // Biomedical Market Newsletter;5/18/2012, Vol. 21, p1 

    The article informs that the U.S. Patent and Trademark Office has granted patent to Codexis Inc.'s biocatalysts and biocatalytic processes used to make key pharmaceutical intermediates in the synthesis of leading hepatitis-C therapeutics. Codexis develops cost-advantaged processes for the...

  • Codexis Awarded Biofuels Enzyme Patent.  // Biomedical Market Newsletter;3/28/2012, Vol. 21, p1 

    The article informs about the issuance of a biofuel enzyme patent to Codexis Inc. by the U.S. Patent and Trademark Office. It states that the patent covers an enzyme group responsible for the conversion of cellulosic biomass to fermentable sugars thereby leading to the production of a wide range...

  • Nature Highlights Advancements in Biocatalysis and its Potential Impact on Production of Biofuels, Renewable Chemicals, and Pharmaceuticals.  // Biomedical Market Newsletter;5/12/2012, Vol. 21, p1 

    The article focuses on a research paper published in the periodical "Nature," which discusses the recent advances in biocatalysis, and its impact on the commercial development of biofuels, renewable chemicals, and pharmaceutical products. The research was conducted by researchers at Codexis...

  • Bio Mail. Jeyakumar, Shadana; Sharma, Dinesh; Nair, Sheethal; Das, Amitava; Khan, Safdar // BioSpectrum;Apr2012, Vol. 10 Issue 4, p8 

    Several letters to the editor are presented in response to articles in previous issues including the philanthropic funding to foster innovation, the chief executive officers (CEOs), and the case study of biomass energy.

  • Shell abandons wind and solar for biofuels focus.  // TCE: The Chemical Engineer;Apr2009, Issue 814, p5 

    The article focuses on the decision of Shell to cease major investment in solar, wind and hydrogen renewables technologies to focus on biofuels. An existing research alliance with the U.S. biotechnology company Codexis has been expanded by the company to enhance the enzymes used to cleave...

  • Entourage meets the best of Tucson technology. Delgado, Steve // Inside Tucson Business;10/14/2002, Vol. 12 Issue 29, p10 

    Reports on the showcase of technological resources to the Canadian delegation of chief executive officers (CEO) in Tucson, Arizona. Duration on the visit of CEO; Assessment of the CEO on the technologies; Participation of the CEO on the knowledge exchange forum in optics and photonics.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics